Cargando…

Molecular Tools for Metastatic Colorectal Cancer Characterization

In our recent publication [1], we have explored at the molecular level the consequences of reovirus administration to patients with KRAS mutated colorectal cancer (CRC). This was the first reported study where transcriptome assay was performed on KRAS mutated CRC patients receiving reovirus (pelareo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maitra, Radhashree, Fogel, Elisha, Parakrama, Ruwan, Goel, Sanjay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793569/ https://www.ncbi.nlm.nih.gov/pubmed/33426543 http://dx.doi.org/10.33696/immunology.2.067

Ejemplares similares

Immune characterization of metastatic colorectal cancer patients post reovirus administration
por: Parakrama, Ruwan, et al.
Publicado: (2020)

Transcriptome Signature of Immune Cells Post Reovirus Treatment in KRAS Mutated Colorectal Cancer
por: Fogel, Elisha J, et al.
Publicado: (2021)

Immunotherapeutic advances in gastrointestinal malignancies
por: Rao, Devika, et al.
Publicado: (2019)

Noncoding RNA Profile in Reovirus Treated KRAS-Mutated Colorectal Cancer Patients
por: Saperstein, Rafael, et al.
Publicado: (2023)

Therapeutic Targets of KRAS in Colorectal Cancer
por: Rahman, Shafia, et al.
Publicado: (2021)

Protein Arginine Methyltransferase 5 as a Therapeutic Target for KRAS Mutated Colorectal Cancer
por: Shifteh, David, et al.
Publicado: (2020)

Telomere length regulation through epidermal growth factor receptor signaling in cancer
por: Augustine, Titto, et al.
Publicado: (2017)

Toll-like receptor 3 as an immunotherapeutic target for KRAS mutated colorectal cancer
por: Maitra, Radhashree, et al.
Publicado: (2017)

Development and Characterization of a Genetic Mouse Model of KRAS Mutated Colorectal Cancer
por: Maitra, Radhashree, et al.
Publicado: (2019)

Oncolytic reovirus preferentially induces apoptosis in KRAS mutant colorectal cancer cells, and synergizes with irinotecan
por: Maitra, Radhashree, et al.
Publicado: (2014)

Potentiating effect of reovirus on immune checkpoint inhibition in microsatellite stable colorectal cancer
por: Augustine, Titto, et al.
Publicado: (2022)

The Synergistic Role of Diet and Exercise in the Prevention, Pathogenesis, and Management of Ulcerative Colitis: An Underlying Metabolic Mechanism
por: Stavsky, Jonah, et al.
Publicado: (2019)

Targeting Estrogens and Various Estrogen-Related Receptors against Non-Small Cell Lung Cancers: A Perspective
por: Maitra, Radhashree, et al.
Publicado: (2021)

A WW-like module in the RAG1 N-terminal domain contributes to previously unidentified protein–protein interactions
por: Maitra, Radhashree, et al.
Publicado: (2009)

BRG1: Promoter or Suppressor of Cancer? The Outcome of BRG1’s Interaction with Specific Cellular Pathways
por: Shaykevich, Aaron, et al.
Publicado: (2023)

Molecular characterization of colorectal cancer related peritoneal metastatic disease
por: Lenos, Kristiaan J., et al.
Publicado: (2022)

Telomere length is a novel predictive biomarker of sensitivity to anti-EGFR therapy in metastatic colorectal cancer
por: Augustine, T A, et al.
Publicado: (2015)

Molecular Characterization of Circulating Tumor Cells in Human Metastatic Colorectal Cancer
por: Barbazán, Jorge, et al.
Publicado: (2012)

Germline Profiling and Molecular Characterization of Early Onset Metastatic Colorectal Cancer
por: Xu, Ting, et al.
Publicado: (2020)

Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin
por: Rao, Devika, et al.
Publicado: (2019)

The role of PARP inhibitors in BRCA mutated pancreatic cancer
por: Chi, Jeffrey, et al.
Publicado: (2021)

Comparative Effectiveness of Biologic Agents Among Black and White Medicare Patients in the US With Metastatic Colorectal Cancer
por: Goel, Sanjay, et al.
Publicado: (2021)

Molecular characterization of pro-metastatic functions of β4-integrin in colorectal cancer
por: Zhang, Wanguang, et al.
Publicado: (2017)

Molecular characterization and biomarker identification in colorectal cancer: Toward realization of the precision medicine dream
por: Goel, Gaurav
Publicado: (2018)

Immunogenecity of Modified Alkane Polymers Is Mediated through TLR1/2 Activation
por: Maitra, Radhashree, et al.
Publicado: (2008)

Molecular Targets for the Treatment of Metastatic Colorectal Cancer
por: Cohen, Romain, et al.
Publicado: (2020)

Molecularly targeted drugs for metastatic colorectal cancer
por: Cheng, Ying-dong, et al.
Publicado: (2013)

COVID-19 and the Immune Response: A Multi-Phasic Approach to the Treatment of COVID-19
por: Sapir, Tzuriel, et al.
Publicado: (2022)

Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer
por: Eide, Peter W., et al.
Publicado: (2021)

Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer
por: Lai, Eleonora, et al.
Publicado: (2020)

Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer
por: Graham, Donna M., et al.
Publicado: (2016)

Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer
por: Taniguchi, Fumitaka, et al.
Publicado: (2021)

Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer
por: Martini, Giulia, et al.
Publicado: (2020)

Molecular features and gene expression signature of metastatic colorectal cancer
por: Poturnajova, Martina, et al.
Publicado: (2021)

Clinical and metabolomic characterization of Brivanib‐Induced hypertension in metastatic colorectal cancer
por: Rattner, Jodi I., et al.
Publicado: (2023)

Metastatic Colorectal Cancer
por: Passardi, Alessandro, et al.
Publicado: (2021)

Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer
por: Chua, W, et al.
Publicado: (2009)

Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer
por: Di Fiore, F, et al.
Publicado: (2010)

Molecular targeted therapy for metastatic colorectal cancer: current and evolving approaches
por: Li, Furong, et al.
Publicado: (2023)

Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer
por: Serna, Garazi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j2h4819j68nrjss00ur0c36vre